Latest news
Loading news…
Mersana Therapeutics develops novel antibody-drug conjugates (ADCs) designed to treat cancer.
Mersana Therapeutics was acquired by Day One Biopharmaceuticals in 2025 for $285M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
189
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Cambridge, Massachusetts, United States
- Diversity spotlight
- Women Led
Key People at Mersana Therapeutics
Chief Science & Technology Officer
Chief Financial Officer
President & CEO
Chief Manufacturing Officer
189
professional contacts at Mersana Therapeutics
Contact execs at Mersana Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Mersana Therapeutics
Loading news…
FAQs about Mersana Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.